United Asset Strategies’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,927
Closed -$909K 230
2022
Q4
$909K Buy
+6,927
New +$895K 0.13% 141
2022
Q3
Sell
-5,607
Closed -$660K 218
2022
Q2
$660K Sell
5,607
-286
-5% -$34K 0.1% 143
2022
Q1
$768K Buy
5,893
+297
+5% +$38.7K 0.1% 133
2021
Q4
$854K Buy
5,596
+3,792
+210% +$587K 0.1% 131
2021
Q3
$292K Sell
1,804
-407
-18% -$68.5K 0.04% 175
2021
Q2
$362K Sell
2,211
-857
-28% -$132K 0.05% 165
2021
Q1
$462K Sell
3,068
-1,155
-27% -$183K 0.07% 152
2020
Q4
$640K Sell
4,223
-545
-11% -$77.9K 0.1% 135
2020
Q3
$646K Sell
4,768
-1,451
-23% -$197K 0.12% 112
2020
Q2
$850K Sell
6,219
-789
-11% -$101K 0.17% 102
2020
Q1
$755K Sell
7,008
-740
-10% -$85.2K 0.19% 98
2019
Q4
$934K Sell
7,748
-124
-2% -$13.8K 0.18% 102
2019
Q3
$783K Sell
7,872
-950
-11% -$99.4K 0.17% 109
2019
Q2
$962K Sell
8,822
-731
-8% -$77.8K 0.22% 98
2019
Q1
$1.07M Sell
9,553
-80
-0.8% -$8.78K 0.25% 98
2018
Q4
$929K Buy
9,633
+3,362
+54% +$357K 0.25% 90
2018
Q3
$765K Sell
6,271
-90
-1% -$10.6K 0.18% 110
2018
Q2
$699K Sell
6,361
-195
-3% -$20.9K 0.18% 113
2018
Q1
$700K Buy
6,556
+411
+7% +$45.6K 0.21% 107
2017
Q4
$656K Buy
+6,145
New +$657K 0.18% 112

Other funds holding IBB

United Asset Strategies's IBB Position: Q1 2023 in Review

United Asset Strategies sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 6,927 shares — an estimated $909K sold.

United Asset Strategies first reported a position in IBB in Q4 2017 and held it in 20 quarters. The position peaked at $1.07M in Q1 2019. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

  • United Asset Strategies reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • United Asset Strategies sold 6,927 iShares Biotechnology ETF shares in Q1 2023, an estimated $909K.
  • United Asset Strategies first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 20 quarters.
  • United Asset Strategies's iShares Biotechnology ETF position peaked at $1.07M in Q1 2019.
  • 866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on United Asset Strategies's 13F filing for Q1 2023, filed 25 Apr 2023.